Armadin
Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.
$255.5MSeries B
Participant8
8VC
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Sep 18, 2026
8VC invests in and builds technology companies in life sciences, healthcare, manufacturing, enterprise software, logistics and defence.
Its Build programme creates companies when the team identifies an opportunity without an existing business to back. This adds a company-formation route to its conventional investment activity, relevant to entrepreneurs developing a technology platform from the outset.
The firm also runs engineering and Bio-IT fellowships connecting emerging technical talent with its companies. These programmes reflect its emphasis on recruiting builders for sectors where software, scientific expertise and physical operations intersect.
Sources
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 3 First participation on record · 1 follow-on
- Funding in participating rounds
- $385.5M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionBigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
ParticipantPrime Minute
Prime Minute develops disaster-response technology combining live intelligence, AI-assisted mission analysis and aerial suppression.
$15MPre-Seed
ParticipantVals AI
Vals AI evaluates AI models on multi-step, economically valuable work across fields such as legal analysis, financial modeling and software engineering. Its private task-specific benchmarks, expert review and developer integrations help companies measure real-world capability and production risks.
$40MSeries A
Participant